LifeSignals today announced that it has received FDA 510(k) clearance for its LX1550 multi-parameter remote monitoring platform.
Fremont, Calif.-based LifeSignals designed to continuously collect patient physiological data from home and in healthcare settings.
Get the full story on our sister site, Medical Design & Outsourcing.
LifeSignals Group announced today that it received FDA 510(k) clearance for its LifeSignals ECG remote monitoring patch platform.
Fremont, Calif.-based LifeSignals developed the platform as a wireless remote monitoring system for healthcare professionals to continuously collect electrocardiography (ECG) and heart rate data in ambulatory, hospital, home and healthcare settings.
Data collected from the platform’s wireless medical biosensor LP1250 transmits wirelessly to a remote, secure server for storage and analysis for screening and monitoring common cardiac arrhythmias like atrial fibrillation, according to the company. The single-use biosensor offers 72-hour data capture, and is lightweight and splash-proof for improved comfort and compliance. Additionally, its single-chip, proprietary LC1100 LifeSignal processor platform allows for secure capture, storage and transmission of data.
LifeSignals’ monitoring technology already has CE Mark ap…